ETHK Labs Inc. (HKG:1931)
0.5000
-0.0100 (-1.96%)
Sep 11, 2026, 3:29 PM HKT
ETHK Labs Revenue
ETHK Labs had revenue of 1.35B CNY in the half year ending June 30, 2026, with 0.02% growth. This brings the company's revenue in the last twelve months to 2.90B, down -5.64% year-over-year. In the year 2025, ETHK Labs had annual revenue of 2.82B, down -10.81%.
Revenue (ttm)
2.90B CNY
Revenue Growth
-5.64%
P/S Ratio
0.24
Revenue / Employee
3.19M CNY
Employees
910
Market Cap
818.19M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.82B | -341.75M | -10.81% |
| Dec 31, 2024 | 3.16B | 74.03M | 2.40% |
| Dec 31, 2023 | 3.09B | 339.58M | 12.35% |
| Dec 31, 2022 | 2.75B | 18.14M | 0.66% |
| Dec 31, 2021 | 2.73B | 302.46M | 12.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 660.27B |
| Charmacy Pharmaceutical | 5.40B |
| Sinco Pharmaceuticals Holdings | 2.22B |
| Sipai Health Technology | 1.83B |
| ClouDr Group | 1.57B |
| 160 Health International | 784.99M |
| Ziyuanyuan Holdings Group | 423.08M |
| Wanjia Group Holdings | 165.39M |
ETHK Labs News
- 11 days ago - ETHK Labs Earnings release: H1 2026 - Filings
- 5 months ago - ETHK Labs Earnings release: H2 2025 - Filings
- 5 months ago - ETHK Labs Annual report: H2 2025 - Filings